UK Digital Health Advisory Panel 2026
13 February 2026 - 5 June 2026
Webinar
Innovation Norway introduces the new UK Digital Health Advisory Panel: your gateway to opportunities in the UK market. Through three digital meet ups in 2026, Norwegian companies will get expert advice to help shape their growth strategies in the UK market.
- Webinar 1: Market Entry and Qualification - Friday 13th February, 12-2pm Norwegian time. Participating advisors:
Jason Leitch CBE
Professor / Patient safety and Healthcare quality expert / Senior Fellow IHI / Former National Clinical Director Scotland
Nicola Haywood-Cleverly
NED | Strategic Advisor | Transformation Lead. FBCS | CHCIO | LPFEDIP | CEng | MIET | MBA
- Webinar 2: Advancing Early Interest and Securing the Offer - Friday 17th April, 12-2pm Norwegian time. Participating advisors:
- Webinar 3: Business Case and Procurement Readiness - Friday 5th June, 12-2pm Norwegian time. Participating advisors:
Who should attend:
Norwegian health and life science companies interested in export, collaboration or partnerships in UK and Ireland.
We expect companies to participate in all three meetings to get the full benefit of the programme. The topics and advisors are chosen to give you the best foundation to build a growth plan for the UK market.
Please note that there are limited spaces available for companies, this is to make sure each company get the follow up they need, and to keep the discussions and meetings dynamic. Please register interest and we will get back to you.
Programme highlights:
- Work on strategy, growth plan or business case through the three meetings
- Get expert advice and input on your company plan
- Share learnings, knowledge, tips and tricks on growth and learn from other Norwegian companies
- At the end of the three meetings companies will get a chance to pitch their plan and get feedback
About the panel:
As part of the Export Initiative on health Innovation Norway will facilitate three digital meetings with the advisory panel through 2026. Each meeting will include up to four advisors, selected according to their expertise and based on the needs of the Norwegian companies. Participating companies may follow up discussions individually with advisors at their own cost in between the meetings.
The main objectives of the panel include:
- Providing expertise in key areas
- Enabling the businesses to anticipate market changes and respond proactively
- Facilitating networking opportunities and relationship-building with stakeholders, where appropriate
- Supporting business innovation and growth through strategic counsel
Practical information
For more information, please contact us:
Maren Jervell Lund
Senior Advisor & TEA Programme
UK and Ireland
Tone Varslot Stave
Head of national export initiative on health and life science, Innovation Norway
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.